SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Oppenheimer Maintains Outperform on Mustang Bio, Lowers Price Target to $13

Oppenheimer maintains Mustang Bio (NASDAQ:MBIO) with a Outperform and lowers the price target from $15 to $13.

Benzinga · 05/12/2020 12:16

Oppenheimer maintains Mustang Bio (NASDAQ:MBIO) with a Outperform and lowers the price target from $15 to $13.